Hydreight Technologies Inc. (HYDTF)

Healthcare · OQB

USD2.90-7.35% today

Fundamentals

Market capUSD173.34M
P/E ratio53.8
Revenue growth (YoY)+449.1%
Profit margin7.6%
Return on equity21.5%
52-week rangeUSD1.60 to USD3.99

Valuation and ratings

DCF fair valueUSD2.31
Upside to fair value-20.3%
Moat score42/100
Overall rating34/100, Reduce

Fair value: USD2.31 (-20.3%), see how we got there

Hydreight Technologies Inc. trades at USD2.90, which is 20% above the USD2.31 our discounted cash flow model puts on the business. On that measure it screens as expensive, which is not the same as saying it will fall.

Our moat model scores it 42 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.

It changes hands at 53.8 times earnings. Be careful reading that in isolation: for a cyclical business a low P/E arrives at the top of the cycle, when profits are peaking and about to fall, which is exactly when the shares look cheapest and are not.

HYDTF earnings and analyst estimates

Next earnings date25 Aug 2026 (in 29 days)

Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.

About Hydreight Technologies Inc.

Hydreight Technologies Inc. operates in the digital health technology sector in the United States. The company develops a proprietary telemedicine service that allows users to book confidential health and wellness, and/or medical services through a mobile application. It also provides consulting and advice in setting up health and wellness services, including assistance with finding experienced advisors in the areas of medical and privacy law, among others; medical liability insurance; pharmaceutical IV programs vetted by duly licensed pharmacists; procedural guides with respect to various services, such as a range of IV therapy treatments, GLP1, NAD, Botox, and fillers; and hiring, on-boarding, training, marketing, branding, payroll, and other accounting services. In addition, the company offers an online pharmacy, which allows its network of medical practitioners to purchase pharmacy products from federally regulated pharmacies. Hydreight Technologies Inc. is headquartered in Las Vegas, Nevada.

Industry: Health Information ServicesHQ: United States

HYDTF passes 3 of our 30 screens today

Each screen prints the exact criteria it used, and the circumstances in which it is wrong.

Common questions

Is Hydreight Technologies Inc. (HYDTF) undervalued?

Against our discounted cash flow estimate of USD2.31, HYDTF at USD2.90 is 20% above fair value. That is one model's answer, not a recommendation, and most of a DCF's output sits in a terminal value nobody can forecast.

What is HYDTF's P/E ratio?

HYDTF trades at 53.8 times earnings. A low P/E is not automatically cheap: on a cyclical company it is usually a warning that earnings are at a peak.

When does HYDTF report earnings next?

Hydreight Technologies Inc. is scheduled to report on 25 Aug 2026. Companies move earnings dates, so read it as scheduled rather than certain.

The full research page for HYDTF, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.

Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.